Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Debra Kristensen

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Vaccine|April 20, 2013
The imperative for stronger vaccine supply and logistics systemsMichel Zaffran, Jos Vandelaer, Debra Kristensen, et al.
Vaccine|November 1, 2008
Development of a freeze-stable formulation for vaccines containing aluminum salt adjuvantsLaToya Jones Braun, Anil Tyagi, Shalimar Perkins, et al.
The Pan African Medical Journal|January 4, 2018
An economic evaluation of the controlled temperature chain approach for vaccine logistics: evidence from a study conducted during a meningitis A vaccine campaign in TogoMercy Mvundura, Patrick Lydon, Abdoulaye Gueye, et al.
Vaccine|August 23, 2013
Development of a fast-dissolving tablet formulation of a live attenuated enterotoxigenic E. coli vaccine candidateManjari Lal, Scott Priddy, Lou Bourgeois, et al.
Bulletin of the World Health Organization|February 12, 2013
Vaccine Presentation and Packaging Advisory Group: a forum for reaching consensus on vaccine product attributesOsman David Mansoor, Debra Kristensen, Andrew Meek, et al.
Vaccine|June 27, 2021
A global collaboration to advance vaccine product innovations - The Vaccine Innovation Prioritisation StrategyDebra Kristensen, Birgitte Giersing, Julian Hickling, et al.
Vaccine|October 10, 2021
Strategies for vaccine-product innovation: Creating an enabling environment for product development to uptake in low- and middle-income countriesBirgitte Giersing, Natasha Shah, Debra Kristensen, et al.
Vaccine|June 16, 2009
Characterization of a thermostable hepatitis B vaccine formulationLaToya Jones Braun, Jan Jezek, Sabrina Peterson, et al.
Vaccine|August 20, 2021
Vaccine innovation prioritisation strategy: Findings from three country-stakeholder consultations on vaccine product innovationsMercy Mvundura, Collrane Frivold, Anna Janik Osborne, et al.
Vaccine|April 14, 2015
Estimating the costs of the vaccine supply chain and service delivery for selected districts in Kenya and TanzaniaMercy Mvundura, Kristina Lorenson, Amos Chweya, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Vaccine|April 20, 2013
The imperative for stronger vaccine supply and logistics systemsMichel Zaffran, Jos Vandelaer, Debra Kristensen, et al.
Vaccine|November 1, 2008
Development of a freeze-stable formulation for vaccines containing aluminum salt adjuvantsLaToya Jones Braun, Anil Tyagi, Shalimar Perkins, et al.
The Pan African Medical Journal|January 4, 2018
An economic evaluation of the controlled temperature chain approach for vaccine logistics: evidence from a study conducted during a meningitis A vaccine campaign in TogoMercy Mvundura, Patrick Lydon, Abdoulaye Gueye, et al.
Vaccine|August 23, 2013
Development of a fast-dissolving tablet formulation of a live attenuated enterotoxigenic E. coli vaccine candidateManjari Lal, Scott Priddy, Lou Bourgeois, et al.
Bulletin of the World Health Organization|February 12, 2013
Vaccine Presentation and Packaging Advisory Group: a forum for reaching consensus on vaccine product attributesOsman David Mansoor, Debra Kristensen, Andrew Meek, et al.
Vaccine|June 27, 2021
A global collaboration to advance vaccine product innovations - The Vaccine Innovation Prioritisation StrategyDebra Kristensen, Birgitte Giersing, Julian Hickling, et al.
Vaccine|October 10, 2021
Strategies for vaccine-product innovation: Creating an enabling environment for product development to uptake in low- and middle-income countriesBirgitte Giersing, Natasha Shah, Debra Kristensen, et al.
Vaccine|June 16, 2009
Characterization of a thermostable hepatitis B vaccine formulationLaToya Jones Braun, Jan Jezek, Sabrina Peterson, et al.
Vaccine|August 20, 2021
Vaccine innovation prioritisation strategy: Findings from three country-stakeholder consultations on vaccine product innovationsMercy Mvundura, Collrane Frivold, Anna Janik Osborne, et al.
Vaccine|April 14, 2015
Estimating the costs of the vaccine supply chain and service delivery for selected districts in Kenya and TanzaniaMercy Mvundura, Kristina Lorenson, Amos Chweya, et al.
Pageof 3